<DOC>
	<DOC>NCT03060707</DOC>
	<brief_summary>The research is to find out whether continuous infusion of rocuronium requires more or less amount of rocuronium, per kilogram and per hour, than bolus administered rocuronium during noncardiac surgery.</brief_summary>
	<brief_title>Continuous Infusion Versus Intermittent Bolus Injection of Rocuronium</brief_title>
	<detailed_description>comparing the total dose of rocuronium between continuous infusion and intermittent injection</detailed_description>
	<mesh_term>Rocuronium</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<criteria>Pediatric patients aged between 2 and 12, undergoing elective noncardiac surgery which requires general anesthesia but does not require intense block, and estimated time of surgery is between 2 and 5 hours ASA class 36 BMI &gt;= 30 Previous history of hepatic failure, renal failure or neuromuscular disease Patients taking medicine which interacts with rocuronium bromide, before or during surgery: aminoglycosides, lincosamides, acylaminopenicillin antibiotics, tetracyclines, metronidazole (high dose), diuretics, MAO inhibitors, calcium channel blockers, corticosteroids, phenytoin, carbamazepine, or norepinephrine Previous history of allergic reaction (including anaphylactic reaction) and/or malignant hyperthermia during general anesthesia Patients taking medicines which contains magnesium</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>